VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,278,532 | -74.6% | 294,004 | -62.5% | 0.00% | -100.0% |
Q2 2023 | $8,966,151 | +316.6% | 783,070 | +180.5% | 0.00% | – |
Q1 2023 | $2,152,379 | +32.0% | 279,167 | +4.5% | 0.00% | – |
Q4 2022 | $1,630,243 | -20.7% | 267,253 | -23.1% | 0.00% | – |
Q3 2022 | $2,057,000 | +173.2% | 347,453 | +172.7% | 0.00% | – |
Q2 2022 | $753,000 | -34.6% | 127,432 | -15.7% | 0.00% | – |
Q1 2022 | $1,151,000 | +1.2% | 151,202 | -64.0% | 0.00% | – |
Q4 2021 | $1,137,000 | -29.9% | 419,810 | -32.0% | 0.00% | – |
Q3 2021 | $1,622,000 | -46.6% | 616,988 | -16.0% | 0.00% | – |
Q2 2021 | $3,035,000 | +39.1% | 734,609 | +58.6% | 0.00% | – |
Q1 2021 | $2,182,000 | -57.4% | 463,278 | -35.3% | 0.00% | -100.0% |
Q4 2020 | $5,121,000 | +1384.3% | 716,333 | +2116.0% | 0.00% | – |
Q3 2020 | $345,000 | -38.1% | 32,325 | -26.6% | 0.00% | – |
Q2 2020 | $557,000 | +82.0% | 44,069 | +31.8% | 0.00% | – |
Q1 2020 | $306,000 | -87.9% | 33,429 | -81.6% | 0.00% | -100.0% |
Q4 2019 | $2,536,000 | -36.3% | 181,703 | -21.5% | 0.00% | 0.0% |
Q3 2019 | $3,983,000 | +781.2% | 231,522 | +1294.2% | 0.00% | – |
Q2 2019 | $452,000 | +11.9% | 16,606 | -21.4% | 0.00% | – |
Q1 2019 | $404,000 | -63.3% | 21,122 | -81.9% | 0.00% | – |
Q4 2018 | $1,100,000 | -83.9% | 117,018 | -67.6% | 0.00% | -100.0% |
Q3 2018 | $6,826,000 | -23.2% | 360,793 | -20.7% | 0.00% | 0.0% |
Q2 2018 | $8,885,000 | +1.4% | 454,719 | -2.5% | 0.00% | 0.0% |
Q1 2018 | $8,763,000 | +206.5% | 466,361 | +170.7% | 0.00% | +100.0% |
Q4 2017 | $2,859,000 | +346.7% | 172,261 | +453.6% | 0.00% | – |
Q3 2017 | $640,000 | +466.4% | 31,117 | +146.0% | 0.00% | – |
Q2 2017 | $113,000 | -81.8% | 12,647 | -73.1% | 0.00% | – |
Q1 2017 | $622,000 | -38.4% | 47,032 | -40.7% | 0.00% | – |
Q4 2016 | $1,010,000 | +3784.6% | 79,270 | +3588.7% | 0.00% | – |
Q3 2016 | $26,000 | +2500.0% | 2,149 | +2049.0% | 0.00% | – |
Q2 2016 | $1,000 | -85.7% | 100 | -88.0% | 0.00% | – |
Q1 2016 | $7,000 | +133.3% | 832 | +576.4% | 0.00% | – |
Q4 2015 | $3,000 | – | 123 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |